Search Results

Identified synthesis and in-vivo study of oxidized metabolites of Rimonabant via LC–ESI–MS technique.

• Authors : Tsai, Shuo-En¹ (AUTHOR); Chung, Cheng-Yen^1,2 (AUTHOR); Li, Sin-Min³ (AUTHOR)

Subjects: *RIMONABANT; *IN vivo studies; *METABOLITES

• Source: Journal of Molecular Structure. Feb2024:Part 1, Vol. 1298, pN.PAG-N.PAG. 1p.

Record details

Modular microfluidic platform for solubility measurement, nucleation statistics and polymorph screening of active pharmaceutical ingredients: Irbesartan, Rimonabant, Aripiprazole and Sulfathiazole.

• Authors : Lambert, Mathilde^1,2 (AUTHOR); Grossier, Romain¹ (AUTHOR) ; Lagaize, Mehdi¹ (AUTHOR)

Subjects: *NUCLEATION; *RIMONABANT; *ARIPIPRAZOLE

• Source: Journal of Crystal Growth. Aug2023, Vol. 616, pN.PAG-N.PAG. 1p.

Record details

Effects of the cannabinoid CB1-receptor neutral antagonist AM4113 and antagonist/inverse agonist rimonabant on fentanyl discrimination in male rats.

• Authors : AlKhelb, Dalal^1,2 (AUTHOR); Kirunda, Andre¹ (AUTHOR); Ho, Thanh C.¹ (AUTHOR)

Subjects: *FENTANYL; *RIMONABANT; *OPIOID abuse

• Source: Drug & Alcohol Dependence. Nov2022, Vol. 240, pN.PAG-N.PAG. 1p.

Record details

Fatty acid flux and oxidation are increased by rimonabant in obese women.

• Authors : Backhouse, Katharine; Sarac, Ivana; Shojaee-Moradie, Fariba

Subjects: FATTY acids; RIMONABANT; CANNABINOID receptors

• Source: Metabolism: Clinical & Experimental; Sep2012, Vol. 61 Issue 9, p1220-1223, 4p

Record details

Rimonabant for neurocognition in schizophrenia: A 16-week double blind randomized placebo controlled trial

• Authors : Boggs, Douglas L.¹; Kelly, Deanna L.²; McMahon, Robert P.²

Subjects: *SCHIZOPHRENIA; *RIMONABANT; *RANDOMIZED controlled trials

• Source: Schizophrenia Research. Feb2012, Vol. 134 Issue 2/3, p207-210. 4p.

Record details

Melancholic features related to rimonabant

• Authors : de Mattos Viana, Bernardo¹ ; Prais, Hugo Alejandro Cano²; Daker, Maurício Viotti^1,3

Subjects: *RIMONABANT; *MENTAL depression; *OBESITY

• Source: General Hospital Psychiatry. Nov2009, Vol. 31 Issue 6, p583-585. 3p.

Record details

Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial.

• Source: The Lancet. 2010, Vol. 376, Issue 9740, pages. 7

Record details

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.

• Authors : Christensen, Robin; Kristensen, Pernelle Kruse; Bartels, Else Marie

• Source: The Lancet. 2007, Vol. 370, Issue 9600, pages. 8

Record details

Drug treatments for obesity: orlistat, sibutramine, and rimonabant.

• Authors : Padwal, Raj S.; Majumdar, Sumit R.

• Source: The Lancet. 2007, Vol. 369, Issue 9555, pages. 7

Record details

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.

• Authors : Scheen, Andre J.; Finer, Nick; Hollander, Priscilla

• Source: The Lancet. 2006, Vol. 368, Issue 9548, pages. 13

Record details